Sinsin Pharmaceutical Co., Ltd. (002800) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sinsin Pharmaceutical Co., Ltd. (002800:KRX), powered by AI.

Current Price
₩4,725
P/E Ratio
7.7
Market Cap
71.7B
Sector
Healthcare
What is the Sinsin Pharmaceutical Co., Ltd. stock price forecast?

Sinsin Pharmaceutical Co., Ltd. is currently trading at ₩4,725. View real-time AI analysis on Alpha Lenz.

What is Sinsin Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Sinsin Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Sinsin Pharmaceutical Co., Ltd.'s P/E ratio?

Sinsin Pharmaceutical Co., Ltd.'s P/E ratio is 7.7.

Sinsin Pharmaceutical Co., Ltd.

KRX · 002800
₩4,725+55(+1.18%)Market closedKRX regular session 09:00–15:30 KST
Ask about Sinsin Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sinsin Pharmaceutical Co., Ltd. trades at a P/E of 7.7 (undervalued) with solid ROE of 13.2%.

Ask for details

Company Overview

Sinsin Pharmaceutical Co., Ltd. is a prominent entity in the healthcare sector, primarily engaged in the production and distribution of pharmaceutical products. Focused on delivering high-quality medication, the company dedicates itself to researching and developing innovative solutions that address various health conditions. Its product lineup includes prescription drugs, over-the-counter remedies, and therapeutic pharmaceuticals designed to meet diverse consumer health needs. Sinsin Pharmaceutical operates within industries such as healthcare, biotechnology, and medical supplies, impacting both domestic and international markets through its widespread distribution channels. As a vital component of the pharmaceutical industry, the company plays a significant role in enhancing global health standards by ensuring accessibility to essential medications and fostering advancements in medical treatment. Headquartered in South Korea, Sinsin Pharmaceutical continues to contribute to the healthcare landscape with a commitment to quality assurance and regulatory compliance, positioning itself as a trusted provider within the medical community.

CEO이병기
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees356

Company Statistics

FY 2025

Profile

₩71,680,612,500Market Cap
₩113,778,253,740Revenue
15.17MShares Out
356Employees

Margins

37.89%Gross
13.69%EBITDA
9.48%Operating
8.62%Pre-Tax
8.16%Net

Valuation

7.71P/E
0.96P/B
0.63EV/Sales
7.14EV/EBITDA
10.28P/FCF

Growth (CAGR)

7.37%Rev 3Yr
11.13%Rev 5Yr
25.75%Op Inc 3Yr
N/AOp Inc 5Yr
28.69%Net Inc 3Yr
115.16%Net Inc 5Yr

Returns

6.95%ROA
13.21%ROE
8.57%ROIC

Financial Health

₩3,876,423,070Cash & Cash Equivalents
₩59,100,718,350Net Debt
84.51%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sinsin Pharmaceutical Co., Ltd. (ticker: 002800) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 356 employees. Market cap is $71.7B.

The current price is ₩4,725 with a P/E ratio of 7.71x and P/B of 0.96x.

ROE is 13.21% and operating margin is 9.48%. Annual revenue is $113.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sinsin Pharmaceutical Co., Ltd. (002800) Stock Forecast 2026 ₩4,725 — Price, Financials & Analyst Targets | Alpha Lenz